An oral cavity carcinoma nomogram to predict benefit of adjuvant radiotherapy

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 6, 2013, Pages 554-559

  Wang, Samuel J ^a   Patel, Snehal G ^c   Shah, Jatin P ^c   Goldstein, David P ^d   Irish, Jonathan C ^d   Carvalho, Andre L ^e   Kowalski, Luiz P ^f   Lockhart, Jennifer L ^a   Holland, John M ^a   Gross, Neil D ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e BARRETOS CANCER HOSPITAL   (Brazil)

^f A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL DECISION MAKING; FAILURE FREE SURVIVAL; FEMALE; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NOMOGRAM; ORAL CAVITY SQUAMOUS CELL CARCINOMA; OUTCOME ASSESSMENT;

BRAZIL; CARCINOMA, SQUAMOUS CELL; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEW YORK; NOMOGRAMS; ONTARIO; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 84879401566     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.3001     Document Type: Article

References (36)

1. Bessell A, Glenny AM, Furness S, et al. Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev. 2011;9(9):CD006205.
2. American Cancer Society. Cancer Facts & Figures. 2013. http://www.cancer.org/Research/CancerFactsFigures. Accessed April 13, 2013.
3. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571-578.
4. Gross ND, Patel SG, Carvalho AL, et al. Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma. Head Neck. 2008;30(10):1352-1360.
5. Harrell FE. Regression Modeling Strategies. New York, NY: Springer-Verlag; 2001.
6. Austin PC. The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making. 2009;29(6):661-677.
7. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
8. Pencina MJ, D'Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109-2123. (Pubitemid 38968032)
9. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361-387. (Pubitemid 26072233)
10. Greene KL, Meng MV, Elkin EP, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol. 2004;171(6, pt 1):2255-2259. (Pubitemid 38625446)
11. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25(15):2035-2041. (Pubitemid 46972788)
12. Rouzier R, Pusztai L, Delaloge S, et al. Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol. 2005;23(33):8331-8339.
13. Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005;23(28):7005-7012.
14. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006;98(10):715-717. (Pubitemid 43821789)
15. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst. 2005;97(10):715-723. (Pubitemid 40872378)
16. Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol. 2000;18(19):3352-3359.
17. Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003;13(2):111-116. (Pubitemid 36288341)
18. Ravdin PM. A computer based program to assist in adjuvant therapy decisions for individual breast cancer patients. Bull Cancer. 1995;82(suppl 5):561s-564s. (Pubitemid 26041511)
19. Ravdin PM. A computer program to assist in making breast cancer adjuvant therapy decisions. Semin Oncol. 1996;23(1)(suppl 2):43-50. (Pubitemid 26105769)
20. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19(4):980-991. (Pubitemid 32176272)
21. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol. 2005;23(12):2716-2725. (Pubitemid 46179461)
22. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293-298. (Pubitemid 38963021)
23. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21(19):3647-3650. (Pubitemid 46594058)
24. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79(387):516- 524.
25. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-2281.
26. Austin PC, Mamdani MM. A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use. Stat Med. 2006;25(12):2084-2106. (Pubitemid 43950281)
27. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083-3107.
28. Boag JW. Maximum likelihood estimates of the proportion of patients cured by cancer therapy. J R Stat Soc Series B Stat Methodol. 1949;11:15-44.
29. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? a study of 14,731 women with breast cancer from the Cancer Registry of Norway. Cancer. 1984;53(8):1793-1800. (Pubitemid 14127527)
30. Gamel JW, Vogel RL, Valagussa P, Bonadonna G. Parametric survival analysis of adjuvant therapy for stage II breast cancer. Cancer. 1994;74(9):2483-2490. (Pubitemid 24320852)
31. Chapman JA, Lickley HL, Trudeau ME, et al. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis. Breast J. 2006;12(1):37-47. (Pubitemid 43381448)
32. Tai P, Chapman JA, Yu E, et al. Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment. BMC Cancer. 2007;7:31.
33. Gamel JW, McLean IW. A stable, multivariate extension of the log-normal survival model. Comput Biomed Res. 1994;27(2):148-155. (Pubitemid 24178506)
34. Cooper JS, Pajak TF, Forastiere AA, et al; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for highrisk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-1944.
35. Bernier J, Domenge C, Ozsahin M, et al; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-1952. (Pubitemid 38580197)
36. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Head & Neck Cancer. 2011. http://www.nccn.org/professionals/ physician-gls/f-guidelines.asp. Accessed November 11, 2012.